日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats.

外周注射选择性可溶性肿瘤坏死因子 (TNF) 抑制剂 XPro®1595 可减轻 6-OHDA 半侧帕金森病大鼠的黑质细胞丢失和神经胶质活化

Barnum Christopher J, Chen Xi, Chung Jaegwon, Chang Jianjun, Williams Martha, Grigoryan Nelly, Tesi Raymond J, Tansey Malú G